Abstract 4751: CS5005: A novel SSTR2-targeted antibody-drug conjugate (ADC) with robust antitumor activity in preclinical studies

Chuan Wang(Qilu Hospital of Shandong University), Jianxin Yang(Ascepion Pharmaceuticals (China)), Jingyu Sun(Soochow University), Xueqin Dai(Ascepion Pharmaceuticals (China)), Yi Sun(Ascepion Pharmaceuticals (China)), Ning Zhang(Ascepion Pharmaceuticals (China)), Yamin Wang(Ascepion Pharmaceuticals (China)), Xuelian Liu(Ascepion Pharmaceuticals (China)), Yongli Yang(Southwest Forestry University), Xinling Zhang(Dalian Maritime University), Yongwang Li(Tianjin University), Fei Ma(Ascepion Pharmaceuticals (China)), Mengyao Zhu(Ascepion Pharmaceuticals (China))
Cancer Research
April 21, 2025
Cited by 0


Related Papers